Seres Therapeutics, Inc. (MCRB) Q3 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Seres Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:05.372 Welcome to the Series Therapeutics Third Quarter 2023 Financial Results Conference 00:00:05.372 -- 00:00:09.294 Call. All participants will be in listen-only mode. 00:00:09.294 -- 00:00:13.777 Should you need assistance, please signal a conference specialist by pressing the star 00:00:13.777 -- 00:00:18.940 key followed by zero. After today's presentation, there will be an opportunity 00:00:18.940 -- 00:00:24.043 to ask questions. To ask a question, you may press star, then one on your 00:00:24.043 -- 00:00:29.366 telephone keypad. To withdraw your question, please press star, then two. 00:00:29.366 -- 00:00:34.208 Please note this event is being recorded. I would now like to turn the conference over 00:00:34.208 -- 00:00:37.889 to Kevin Mannix, head of investor relations. 00:00:37.889 -- 00:00:40.289 Please go ahead. 00:00:40.550 -- 00:00:42.710 Thank you, Dave, and good morning, everyone. 00:00:42.710 -- 00:00:46.031 Our press release for the company's third quarter 2023 00:00:46.031 -- 00:00:49.952 financial results and business update became available at 7 a.m. 00:00:49.952 -- 00:00:54.474 Eastern time this morning and can be found on the investor and news section of the company's 00:00:54.474 -- 00:00:58.901 website. I'd like to remind you that we'll be making forward-looking statements, including 00:00:58.901 -- 00:01:04.063 the availability of cash to fund operations, the potential sales for Vaust, 00:01:04.063 -- 00:01:09.145 the timing and results of clinical studies, our ability to achieve sales targets, and 00:01:09.145 -- 00:01:12.026 other statements which are not historical fact. 00:01:12.026 -- 00:01:16.467 Actual results may differ materially. Additionally, these statements are subject to certain 00:01:16.467 -- 00:...